Key result
Patients with progressive coronary artery disease had higher mean arterial blood pressure compared to those with nonprogressive disease.
Why the study?
Are higher blood pressure and LDL-C levels associated with angiographic progression of coronary artery disease in outpatients?
Observational (n=183)
No
Are higher blood pressure and LDL-C levels associated with angiographic progression of coronary artery disease in outpatients?
Higher mean arterial blood pressure is significantly associated with angiographic progression of coronary artery disease in outpatients.
Answers are grounded in this paper and cite their sources.
Should not yet alter BP targets in CAD outpatients; hypothesis-generating for trials testing whether MAP reduction slows progression.
INTRODUCTION: To investigate differences between outpatients with progressive and nonprogressive coronary artery disease (CAD) measured by coronary angiography. MATERIAL AND METHODS: Chart reviews were performed in patients in an outpatient cardiology practice having ≥ 2 coronary angiographies ≥ 1 year apart. Progressive CAD was defined as 1) new non-obstructive or obstructive CAD in a previously disease-free vessel; or 2) new obstruction in a previously non-obstructive vessel. Coronary risk factors, comorbidities, cardiovascular events, medication use, serum low-density lipoprotein cholesterol (LDL-C), and blood pressure were used for analysis. RESULTS: The study included 183 patients, mean age 71 years. Mean follow-up duration was 11 years. Mean follow-up between coronary angiographies was 58 months. Of 183 patients, 108 (59%) had progressive CAD, and 75 (41%) had nonprogressive CAD. The use of statins, β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and aspirin was not significantly different in patient with progressive CAD or nonprogressive CAD Mean arterial pressure was higher in patients with progressive CAD than in patients with nonprogressive CAD (97±13 mm Hg vs. 92±12 mm Hg) (p<0.05). Serum LDL-C was insignificantly higher in patients with progressive CAD (94±40 mg/dl) than in patients with nonprogressive CAD (81±34 mg/dl) (p=0.09). CONCLUSIONS: Our data suggest that in addition to using appropriate medical therapy, control of blood pressure and serum LDL-C level may reduce progression of CAD.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2012) conducted an observational in Coronary artery disease (n=183). Progressive coronary artery disease vs. Nonprogressive coronary artery disease was evaluated on Mean arterial blood pressure (mm Hg) (p=0.01). Patients with progressive coronary artery disease had higher mean arterial blood pressure compared to those with nonprogressive disease.
Synapse has enriched 10 related papers. Consider them for comparative context: